Seya Mizuki, Aokage Toshiyuki, Nojima Tsuyoshi, Nakao Atsunori, Naito Hiromichi
Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.
Eur J Med Res. 2022 Oct 29;27(1):224. doi: 10.1186/s40001-022-00863-0.
Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
胆汁色素,如胆红素和胆绿素,是哺乳动物血红素降解途径的终产物,因其细胞毒性作用而广为人知。然而,最近的研究表明,它们通过抗氧化、抗炎和免疫抑制特性发挥细胞保护作用。所有这些机制在急诊和重症医学领域的疾病治疗中都是不可或缺的,如冠状动脉缺血、中风、脑脊髓炎、急性肺损伤/急性呼吸窘迫综合征、肠系膜缺血和脓毒症。虽然在临床环境中安全应用胆汁色素之前还需要进一步研究,但它们的潜在机制为其在急诊和重症医学领域作为治疗剂的应用提供了线索。本文旨在总结目前对胆汁色素的认识,并重新评估它们在上述疾病中的治疗潜力。